Unique Ingredient Identifier I753WB2F1M is listed as a ingredient substance
RN | 1934-21-0 |
EC | 217-699-5 |
NCIT | C71681 |
RXCUI | 1305578 |
MF | C16H9N4O9S2.3Na |
INCHI KEY | YXHBBEQKMVAJOH-GLCFPVLVSA-K |
SMILES | [Na+].[Na+].[Na+].OC1=C(\N=N\C2=CC=C(C=C2)S([O-])(=O)=O)C(=NN1C3=CC=C(C=C3)S([O-])(=O)=O)C([O-])=O |
UNII I753WB2F1M FD&C YELLOW NO. 5 is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
BUCCAL/SUBLINGUAL | TABLET | 0.11 MG |
ORAL | CAPSULE | 652 MG |
ORAL | CAPSULE (IMMED./COMP. RELEASE) | 0.027 MG |
ORAL | CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELAT | 0.26 MG |
ORAL | CAPSULE, HARD GELATIN | NA |
ORAL | CAPSULE, SOFT GELATIN | NA |
ORAL | CAPSULE, SUSTAINED ACTION | 0.26 MG |
ORAL | SOLUTION | 1 MG/1ML |
ORAL | SOLUTION, ELIXIR | 0.1 MG/5ML |
ORAL | SUSPENSION | NA |
ORAL | SYRUP | 0.1 MG |
ORAL | TABLET | 180 MG |
ORAL | TABLET, COATED | 7.93 MG |
ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | NA |
ORAL | TABLET, EXTENDED RELEASE | 1.33 MG |
ORAL | TABLET, FILM COATED | 1.68 MG |
ORAL | TABLET, SUSTAINED ACTION | 0.11 MG |
ORAL | TABLET, SUSTAINED ACTION, COATED | 0.76 MG |
SUBLINGUAL | TABLET | 0.1 MG |
TOPICAL | EMULSION, CREAM | 0.004 %W/W |
TOPICAL | POWDER | NA |
TOPICAL | SHAMPOO, SUSPENSION | NA |
TOPICAL | SOLUTION | 0.006 %W/W |
TOPICAL | SPONGE | 0.06 %W/W |
VAGINAL | EMULSION, CREAM | 0.004 % |
VAGINAL | SUPPOSITORY | NA |